Fortfahren mit
E5625
Ergocryptin
Synonym(e):
12′-Hydroxy-2′-(1-methylethyl)-5′-α-(2-methylpropyl)-ergotaman-3′,6′,18-trion
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Über diesen Artikel
Empirische Formel (Hill-System):
C32H41N5O5
CAS-Nummer:
Molekulargewicht:
575.70
UNSPSC Code:
12352200
PubChem Substance ID:
EC Number:
208-121-2
MDL number:
solubility
45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.3 mg/mL, ethanol: 3.2 mg/mL, H2O: insoluble
storage temp.
−20°C
SMILES string
CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
Biochem/physiol Actions
Ergot alkaloid
signalword
Warning
hcodes
pcodes
Hazard Classifications
Repr. 2
Lagerklasse
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
J A Mattheij et al.
European journal of endocrinology, 132(1), 91-96 (1995-01-01)
The cause of formation of luteinized unruptured follicles (LUF) is unknown. Formation of LUF was studied after injection of a varying small dose of luteinizing hormone (LH) with or without subsequent injection of gonadotrophin-releasing hormone (GnRH); in addition, the effect
D J Smith et al.
Journal of animal science, 80(6), 1616-1622 (2002-06-25)
Purified ergopeptine alkaloids are often used in studies related to tall fescue toxicosis without regard to epimerization that occurs when ergopeptines are solvated. The objectives of this study were to measure the rates of alpha-ergocryptine epimerization to alpha-ergocryptinine at room
J R Strickland et al.
American journal of veterinary research, 55(5), 716-721 (1994-05-01)
Cultured rat pituitary cells were studied to: determine the effects of ergovaline and loline on in vitro prolactin release; delineate the agonistic activity of these alkaloids at the D2 dopamine receptor, using 2 selective D2 dopamine receptor antagonists; and compare